- Rare kidney tumors often look like harmless cysts on scans.
- Boys and adult women are most likely to be affected.
- Surgery and lab tests are needed to confirm the diagnosis.
Doctors often mistake this rare kidney tumor for a harmless cyst.
Imagine finding a lump on your kidney scan. Doctors say it looks like a harmless water bubble. But sometimes, that bubble hides something more serious.
This discovery changes how we see kidney lumps.
Why kidney lumps cause worry
Kidney cysts are very common. Most people have them by age 50. Usually, they are just fluid-filled sacs. They do not cause pain. They do not grow into cancer.
But some lumps are different. They are called cystic nephromas. These are rare tumors. They are not cancer. But they can look like cancer on images.
This confusion causes stress for patients. It also makes doctors hesitate. They might suggest surgery when it is not needed. Or they might miss a tumor that needs care.
The surprising scan mistake
We used to think scans were enough. Doctors look at pictures of the kidney. They score the lumps based on how they look.
But here’s the twist. This study shows scans fail often. Out of six patients, five were misdiagnosed. They were told they had simple cysts.
The scans showed multilocular cysts. This means many small pockets. The walls had thin lines called septa. These lines can look scary.
Doctors often call this Bosniak II–III. It is a score for risk. But even with this score, mistakes happen. The tumor looked benign. It acted benign. But it was not a simple cyst.
This does not mean you should panic about your scan results.
How cells tell the truth
Think of the kidney like a fruit. A cyst is like a juice pocket. This tumor is like a pocket with strange walls.
The walls have special cells. They look like hobnails under a microscope. This is a key clue. Simple cysts do not have these cells.
Doctors use special stains to check. They look for PAX-8 and ER/PR. These are chemical markers. They act like ID cards for the cells.
If the cells have these markers, the diagnosis is clear. This is called immunohistochemistry. It is the gold standard. It confirms what the scan could not.
Researchers looked at six patients. They studied cases from 2010 to 2024. All patients had surgery. Some had part of the kidney removed. Others had the whole kidney removed.
In one case, doctors used a frozen section. This is a quick test during surgery. They freeze the tissue and look at it. It helped them decide how much to cut.
The results were clear. All six patients had cystic nephromas. But only after surgery did they know. The preoperative diagnosis was wrong in most cases.
This shows why tissue is king. Pictures are helpful. But they are not perfect. You need to see the cells.
Why testing matters most
Experts say surgery is key. Removing the tumor prevents confusion later. It also stops any growth.
But the type of surgery matters. Some patients kept their kidney. Others lost it. The frozen section helped guide this choice.
It is a balance. You want to save the kidney. But you must remove the tumor. If you are unsure, removing more is safer.
This study highlights a gap in care. We need better ways to tell the difference. Scans are not enough. We need to look closer.
What happens next
More studies are needed. This group was small. Only six people were involved. It was done at one hospital.
We need larger groups to confirm this. We need to see if the pattern holds. But the message is clear. Pathology is the answer.
Doctors will keep using surgery to be safe. They will check the tissue carefully. This ensures the right treatment for each person.
Research takes time. Approval takes time. But knowing the truth helps patients now. It reduces fear. It guides the next step.
